Fresenius Medical Care AG / DE0005785802

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from October 27, 2025 to October 31, 2025 (each inclusive), 217,659 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
27 October 2025	12,000	46.6650	559,980.33	XETA
28 October 2025	31,250	46.5237	1,453,866.77	XETA
29 October 2025	131,250	46.7301	6,133,327.49	XETA
30 October 2025	5,637	46.7146	263,330.36	XETA
31 October 2025	37,522	46.6476	1,750,312.08	XETA

A total of 4,352,783 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.